Observational Study for Osteochondritis Dissecans of the Knee
This is an observational study for people diagnosed with osteochondritis dissecans (OCD) of the knee, a condition where a piece of bone and cartilage separates from the end of a bone. The study aims to understand how OCD progresses, what treatments are used, and how they affect patients over time, especially athletes. You can join if your OCD diagnosis is confirmed by an X-ray or MRI. There are no specific interventions or treatments being tested in this study; instead, researchers will simply collect information about your regular care. Success for this study means gathering valuable information from 3000 participants over many years to better understand OCD. The current recruitment status is unclear.
- Study design
- This is an observational study involving 3000 participants. It is not testing a new treatment, but rather collecting information about patients' experiences with osteochondritis dissecans.
- What's involved
- You will complete a medical history form and several questionnaires at your first visit. Mandatory surveys will also be collected at 2, 5, 10, and 25 years, and you can complete them at home if you can't return to the clinic.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for up to 50 years, or until their OCD lesion is successfully healed.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Osteochondritis Dissecans of Knee Prospective Cohort
At a glance
Conditions
NCT02771496
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
University of Pennsylvania
Philadelphia, Pennsylvaniastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- James L Carey, MD · PRINCIPAL_INVESTIGATOR · University of Pennsylvania
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- IKDC questionnairebaseline up to 50 years
The primary outcome endpoint for this study is the patient's score on the IKDC Subjective questionnaire, or PEDI-IKDC Subjective questionnaire for patients under 18 years of age.
- PEDI-IKDC questionnairebaseline up to 50 years
The primary outcome endpoint for this study is the patient's score on the IKDC Subjective questionnaire, or PEDI-IKDC Subjective questionnaire for patients under 18 years of age.